CIRM Funded Clinical Trials

A Phase I/IIa Study to Evaluate the Efficacy of Toca 511/Toca FC with Standard of Care Therapy in Newly Diagnosed High Grade Glioma

Disease Area:
Investigator:
CIRM Grant:
CLIN2-15311 (Active)
Award Value:
$11,807,220.00
Trial Sponsor:
University of California, San Francisco
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov